UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Looking for value? Find out what credit card has the best rewards and no annual fee to maximize your financial benefits without added costs.
28,655 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Marvell Technology has surged dramatically, but can it keep delivering value for investors? This guide dives into the...
X-Energy stock faced a sharp 19.2% drop this week after project delays and a downgrade. This article breaks down the ...
Datadog’s stock rally reflects a larger trend: enterprises want visibility into cloud and AI spend. This article brea...
A steep stock drop can force tough choices. This article analyzes why a full exit from Cogent could matter to investo...
StubHub's 2025 earnings narrative centers on the core marketplace while AI-driven product bets unfold in the backgrou...
As AI workloads surge, data centers need faster, smarter networking. This piece examines the potential of a predictio...
This article breaks down APi Group's Q1 2026 earnings call, translating the numbers into actionable takeaways for inv...
As AI stocks surge, Wall Street may signal overvaluation. I break down the arguments, share why I disagree, and give ...
As crypto and precious metals slide, investors eye Robert Kiyosaki’s stance. He emphasizes context over price, signal...